Lymphocyte immune globulin, anti-thy (equine) Interactions
There are 174 drugs known to interact with lymphocyte immune globulin, anti-thy (equine), along with 2 disease interactions. Of the total drug interactions, 47 are major, 118 are moderate, and 9 are minor.
- View all 174 medications that may interact with lymphocyte immune globulin, anti-thy (equine)
- View lymphocyte immune globulin, anti-thy (equine) disease interactions (2)
Most frequently checked interactions
View interaction reports for lymphocyte immune globulin, anti-thy (equine) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Adrenalin (epinephrine)
- Akineton (biperiden)
- Aldactone (spironolactone)
- Aldomet (methyldopa)
- Amaryl (glimepiride)
- Amoxil (amoxicillin)
- Anafranil (clomipramine)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Apresoline (hydralazine)
- AquADEKs (multivitamin with minerals)
- Aramine (metaraminol)
- Atrovent (ipratropium)
- B Complex 100 (multivitamin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Brevibloc (esmolol)
- Bricanyl (terbutaline)
- BuSpar (buspirone)
- Capoten (captopril)
- Carduran (doxazosin)
- Cataflam (diclofenac)
- Centrum (multivitamin with minerals)
- Cernevit (multivitamin)
- Childrens Chewable Multivitamins (multivitamin)
- Cipro (ciprofloxacin)
- Citrucel (methylcellulose)
- Creon (pancrelipase)
- Lasix (furosemide)
- Paracetamol (acetaminophen)
Lymphocyte immune globulin, anti-thy (equine) disease interactions
There are 2 disease interactions with lymphocyte immune globulin, anti-thy (equine) which include:
Report options
More about lymphocyte immune globulin, anti-thy (equine)
- lymphocyte immune globulin, anti-thy (equine) consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Promacta
Promacta is used to prevent bleeding episodes in patients with chronic immune (idiopathic) ...
Alvaiz
Alvaiz (eltrombopag) is an oral thrombopoietin receptor agonist that may be used to treat certain ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Leukine
Leukine increases white blood cells and decreases the risk of infection in conditions such as ...
Sargramostim
Sargramostim is used for aplastic anemia, bone marrow transplantation, bone marrow transplantation ...
Eltrombopag
Eltrombopag is used for aplastic anemia, immune thrombocytopenia, thrombocytopenia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.